These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 25446919

  • 21. Resolvin E1 protects the rat heart against reperfusion injury.
    Keyes KT, Ye Y, Lin Y, Zhang C, Perez-Polo JR, Gjorstrup P, Birnbaum Y.
    Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H153-64. PubMed ID: 20435846
    [Abstract] [Full Text] [Related]

  • 22. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
    Sato T, Tanno M, Miki T, Yano T, Sato T, Shimamoto K, Miura T.
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
    [Abstract] [Full Text] [Related]

  • 23. Ethyl pyruvate attenuates myocardial ischemia-reperfusion injury exacerbated by hyperglycemia via retained inhibitory effect on HMGB1.
    Soh S, Jun JH, Song JW, Shin EJ, Kwak YL, Shim JK.
    Int J Cardiol; 2018 Feb 01; 252():156-162. PubMed ID: 29169909
    [Abstract] [Full Text] [Related]

  • 24. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion.
    Tada H, Kagaya Y, Takeda M, Ohta J, Asaumi Y, Satoh K, Ito K, Karibe A, Shirato K, Minegishi N, Shimokawa H.
    Cardiovasc Res; 2006 Aug 01; 71(3):466-77. PubMed ID: 16781691
    [Abstract] [Full Text] [Related]

  • 25. Hyperglycemia attenuates myocardial preconditioning of remifentanil.
    Kim HS, Kim SY, Kwak YL, Hwang KC, Shim YH.
    J Surg Res; 2012 May 15; 174(2):231-7. PubMed ID: 21392805
    [Abstract] [Full Text] [Related]

  • 26. Salvianolic acid A demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury.
    Pan H, Li D, Fang F, Chen D, Qi L, Zhang R, Xu T, Sun H.
    J Cardiovasc Pharmacol; 2011 Nov 15; 58(5):535-42. PubMed ID: 21795988
    [Abstract] [Full Text] [Related]

  • 27. The protective effects of emulsified isoflurane on myocardial ischemia and reperfusion injury in rats.
    Hu ZY, Luo NF, Liu J.
    Can J Anaesth; 2009 Feb 15; 56(2):115-25. PubMed ID: 19247759
    [Abstract] [Full Text] [Related]

  • 28. A labdane diterpene exerts ex vivo and in vivo cardioprotection against post-ischemic injury: involvement of AKT-dependent mechanisms.
    Cuadrado-Berrocal I, Gómez-Gaviro MV, Benito Y, Barrio A, Bermejo J, Fernández-Santos ME, Sánchez PL, Desco M, Fernández-Avilés F, Fernández-Velasco M, Boscá L, de Las Heras B.
    Biochem Pharmacol; 2015 Feb 15; 93(4):428-39. PubMed ID: 25557296
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I/R) injury mainly via Akt/hexokinase II independent of ERK/GSK-3β pathway.
    Min J, Wei C.
    Biomed Pharmacother; 2017 Mar 15; 87():419-426. PubMed ID: 28068632
    [Abstract] [Full Text] [Related]

  • 31. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion.
    Lipsic E, van der Meer P, Henning RH, Suurmeijer AJ, Boddeus KM, van Veldhuisen DJ, van Gilst WH, Schoemaker RG.
    J Cardiovasc Pharmacol; 2004 Oct 15; 44(4):473-9. PubMed ID: 15454856
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effective glycaemic control critically determines insulin cardioprotection against ischaemia/reperfusion injury in anaesthetized dogs.
    Yu Q, Zhou N, Nan Y, Zhang L, Li Y, Hao X, Xiong L, Lau WB, Ma XL, Wang H, Gao F.
    Cardiovasc Res; 2014 Jul 15; 103(2):238-47. PubMed ID: 24845581
    [Abstract] [Full Text] [Related]

  • 35. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
    Huang C, Cui Y, Ji L, Zhang W, Li R, Ma L, Xing W, Zhou H, Chen B, Yu J, Zhang H.
    Pharm Biol; 2013 Apr 15; 51(4):463-73. PubMed ID: 23336403
    [Abstract] [Full Text] [Related]

  • 36. Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway.
    Miki T, Miura T, Tanno M, Nishihara M, Naitoh K, Sato T, Takahashi A, Shimamoto K.
    Basic Res Cardiol; 2007 Mar 15; 102(2):163-70. PubMed ID: 16944359
    [Abstract] [Full Text] [Related]

  • 37. Downregulation of RACK1 is associated with cardiomyocyte apoptosis after myocardial ischemia/reperfusion injury in adult rats.
    Qian L, Shi J, Zhang C, Lu J, Lu X, Wu K, Yang C, Yan D, Zhang C, You Q, Liu X.
    In Vitro Cell Dev Biol Anim; 2016 Mar 15; 52(3):305-313. PubMed ID: 26659395
    [Abstract] [Full Text] [Related]

  • 38. Overexpression of TIMP3 Protects Against Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Apoptosis Through ROS/Mapks Pathway.
    Liu H, Jing X, Dong A, Bai B, Wang H.
    Cell Physiol Biochem; 2017 Mar 15; 44(3):1011-1023. PubMed ID: 29179205
    [Abstract] [Full Text] [Related]

  • 39. Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats.
    Ren-an Q, Juan L, Chuyuan L, Wenjuan F, Chunyan H, Xuemei Y, Lin H, Hong N.
    J Ethnopharmacol; 2014 Oct 28; 156():190-8. PubMed ID: 25178948
    [Abstract] [Full Text] [Related]

  • 40. Effect of Salvia miltiorrhiza and ligustrazine injection on myocardial ischemia/reperfusion and hypoxia/reoxygenation injury.
    Huang W, Yang Y, Zeng Z, Su M, Gao Q, Zhu B.
    Mol Med Rep; 2016 Nov 28; 14(5):4537-4544. PubMed ID: 27748867
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.